Contineum Therapeutics, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
DE
Business Address
3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA, 92121
Mailing Address
3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA, 92121
Phone
(858) 333-5280
Fiscal Year End
1231
EIN
271467257
Financial Overview
FY2025
-$42.26M
Net Income
$276.64M
Total Assets
$15.65M
Total Liabilities
$260.99M
Stockholders' Equity
$75.60M
Cash & Equivalents
$-2.17
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 5, 2026 | View on SEC |
| 10-K Annual financial report | March 5, 2026 | View on SEC |
| 424B5 Prospectus supplement | March 5, 2026 | View on SEC |
| 4 Insider stock transaction report | March 2, 2026 | View on SEC |
| 4 Insider stock transaction report | March 2, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 20, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 17, 2026 | View on SEC |
Annual Reports
10-K
March 5, 2026
- Successfully completed patient enrollment for CTNM-001 Phase 2 clinical trial in Q3 2025, with topline data anticipated in Q2 2026.
- CTNM-002 granted Orphan Drug Designation in Q1 2025, with an Investigational New Drug (IND) application filing expected in Q4 2026.
Insider Trading
STRONG SELL
3 insiders
17 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.